Drug Patent Expirations in November 2009

Drug Patent Expirations for November 2009

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
ACULAR LS	Allergan	ketorolac tromethamine	5,110,493*PED	Nov 5, 2009
ACULAR	Allergan	ketorolac tromethamine	5,110,493*PED	Nov 5, 2009
PREVPAC	Takeda Pharms Na	amoxicillin; clarithromycin; lansoprazole	4,628,098*PED	Nov 10, 2009
PREVACID IV	Takeda Pharms Na	lansoprazole	4,628,098*PED	Nov 10, 2009
ACEON	Solvay Pharms	perindopril erbumine	5,162,362	Nov 10, 2009
PREVACID	Takeda Pharms Na	lansoprazole	4,628,098*PED	Nov 10, 2009
PREVACID NAPRAPAC 500 (COPACKAGED)	Takeda Pharms Na	lansoprazole; naproxen	4,628,098*PED	Nov 10, 2009
CARDENE	Ekr Therap	nicardipine hydrochloride	5,164,405	Nov 17, 2009
TROVAN PRESERVATIVE FREE	Pfizer	alatrofloxacin mesylate	5,164,402	Nov 17, 2009
RESCULA	R Tech Ueno Ltd	unoprostone isopropyl	5,166,178	Nov 24, 2009
ATROVENT HFA	Boehringer Ingelheim	ipratropium bromide	5,766,573	Nov 28, 2009
PROAIR HFA	Teva Global	albuterol sulfate	6,352,684	Nov 28, 2009
QVAR 40	Teva Global	beclomethasone dipropionate	5,766,573	Nov 28, 2009
XOPENEX HFA	Sepracor	levalbuterol tartrate	6,352,684	Nov 28, 2009
QVAR 80	Teva Global	beclomethasone dipropionate	6,352,684	Nov 28, 2009
PROAIR HFA	Teva Global	albuterol sulfate	5,766,573	Nov 28, 2009
PROVENTIL-HFA	3m	albuterol sulfate	6,352,684	Nov 28, 2009
QVAR 40	Teva Global	beclomethasone dipropionate	6,352,684	Nov 28, 2009
QVAR 80	Teva Global	beclomethasone dipropionate	5,766,573	Nov 28, 2009
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

October 26, 2009

26 Oct 2009

Biologic data exclusivity: The arguments for and against it

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:

Why data exclusivity is the new patent protection
Peter J Pitts, Center for medicine in the public interest

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski(a) and Elizabeth A Jex(b)
a) Office of Policy Planning, Federal Trade Commission
b) FTC Office of Policy Planning

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

October 20, 2009

20 Oct 2009

Kyoto Prize Journalism Fellowship

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made outstanding lifetime achievements in technology, science, or the arts. This year’s laureates are:

Dr. Isamu Akasaki, Blue LED pioneer

Drs. Peter and Rosemary Grant, Evolutionary Biologists

Pierre Boulez, World-renowned composer, conductor

I am honored to have the opportunity to attend this prestigious event and to learn more about innovation in diverse disciplines.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology, Talks and Publications

October 2, 2009

02 Oct 2009

Drug Patent Expirations in October 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in October 2009

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
BREATHTEK UBT FOR H-PYLORI	Otsuka America	urea, c-13	4,830,010	Oct 27, 2009
CEDAX	Sciele Pharma Inc	ceftibuten dihydrate	4,634,697	Oct 1, 2009
COLGATE TOTAL	Colgate Palmolive	sodium fluoride; triclosan	5,156,835	Oct 20, 2009
COVERA-HS	Gd Searle Llc	verapamil hydrochloride	5,785,994	Oct 22, 2009
DOXIL	Ortho Biotech	doxorubicin hydrochloride	5,013,556	Oct 20, 2009
DOXIL	Ortho Biotech	doxorubicin hydrochloride	5,213,804	Oct 20, 2009
FLOMAX	Boehringer Ingelheim	tamsulosin hydrochloride	4,703,063	Oct 27, 2009
INVEGA SUSTENNA	Johnson And Johnson	paliperidone palmitate	5,254,556	Oct 27, 2009
MERETEK UBT KIT (W/ PRANACTIN)	Otsuka America	urea, c-13	4,830,010	Oct 27, 2009
PERMAX	Valeant Pharm Intl	pergolide mesylate	5,114,948	Oct 19, 2009